Abstract The root bark of Semialarium mexicanum (Miers) Mennega (cancerina) is traditionally used in Mexico to treat cancer. However, there are no studies supporting its use. We evaluated whether S. mexicanum root bark induces cytotoxicity in breast cancer cells to determine if it has potential applications in the treatment of this disease. Extracts of S. mexicanum root bark in petroleum ether, ethanol, and water were obtained by ultrasound-assisted extraction. MTT and WST-1 assays were used to evaluate the cytotoxicity of the extracts toward breast cancer cells (MDA-MB-231 and MCF7), non-tumorigenic breast-derived cells (MCF 10A), and peripheral blood mononuclear cells (PBMCs). For the extract with greatest cytotoxicity, induction of apoptosis and oxidative stress were determined using flow cytometry. The extract was fractionated, and the cytotoxicity of its fractions was evaluated with the four cell types. The fractions were also analyzed by HPLC. Only the petroleum ether extract was cytotoxic for all cell types (MDA-MB-231 [ MCF 10A/ MCF7 [ PBMCs). Cell death occurred by apoptosis, which could be associated with the induction of oxidative stress. Two fractions that were highly cytotoxic for breast cancer cells were obtained from this extract (IC 50-B 4.15 lg/mL for the most active fraction at 72 h). The MCF 10A cells were less affected, while PBMCs were not affected after 72 h of treatment. Pristimerin was identified in both fractions and may be partially responsible for the cytotoxic effect. These results suggest that S. mexicanum root bark has a potential application in breast cancer treatment.
Introduction
Cancer is one of the leading causes of death in the world (Torre et al. 2015) . In the last 10 years, the number of cancer cases increased by 33% (Global Burden of Disease Cancer 2017), and it is estimated that the number of cases and deaths will continue to increase (Torre et al. 2015) . Breast cancer is the most common type and causes the highest number of deaths among women worldwide (Global Burden of Disease Cancer 2017).
Natural products are important sources of active compounds with medical applications, including the treatment of cancer (Dholwani et al. 2008 ). More than 60% of the drugs used against cancer were isolated from natural sources (Seelinger et al. 2012) , and plants are the most important resources (Alonso-Castro et al. 2011) . There is a plethora of active compounds in plants that have yet to be discovered and exploited, which may help to reduce the dramatic cancer statistics expected in the future. A great variety of plant species are traditionally used in Mexico for the treatment of cancer (Alonso-Castro et al. 2011) , such as Semialarium mexicanum (Miers) Mennega. It is a woody plant that inhabits the tropical deciduous forest of the country (Cáceres-Castillo et al. 2008) . It is a member of the family Celastraceae and is also known as Hemiangium excelsum (Kunth) A.C.Sm., Hippocratea excelsa Kunth, Hippocratea mexicana Miers, Hippocratea uniflora Moc. & Sessé ex DC, and Prionostemma setuliferum Miers according to The Plant List (http://www.theplantlist.org/ tpl1.1/record/kew-2480810). The root bark of this species is popularly known as ''cancerina'' and has been traditionally used to treat cancer (Alonso-Castro et al. 2011) .
Semialarium mexicanum has been poorly studied scientifically to determine if it actually has the anticancer properties attributed by its ethnopharmacological use. There is only one report in which extracts of the whole root of S. mexicanum obtained in petroleum ether, ethyl acetate, and methanol were assayed to determine their cytotoxicity in KB (nasopharyngeal carcinoma), UISO-SQC-1 (squamous cervix carcinoma), and HCT-15 COLADCAR (colon carcinoma) human cell lines. The extract obtained in petroleum ether showed the highest cytotoxic activity in the three cell lines, with IC 50 values of 0.76 (HCT-15), 0.004 (KB), and 0.006 (UISO) lg/mL after 72 h of treatment (Popoca et al. 1998) .
Although there are few studies on the cytotoxic activity of S. mexicanum, there are several reports about the activity of the quinone methide triterpenes pristimerin and tingenone present in S. mexicanum, as well as other members of the Celestraceae family. These two molecules have promising potential as therapeutic and chemopreventive agents against cancer (Gomes et al. 2011) . The cytotoxic activity of pristimerin has been evidenced in different cancer-derived cell lines and animal models. It has been shown to inhibit cell proliferation both in vitro and in vivo, as well as angiogenesis and metastatic processes. Pristimerin has effects on the cell cycle, apoptosis, proteasome activity, the generation of reactive oxygen species (ROS), and the NF-jB, AKT/mTOR, and MAPK/ERK pathways (Bashir et al. 2017) .
Tingenone has been shown to have antimitotic effects, it induces apoptosis in vitro (probably because of its interaction with caspases), and it inhibits RNA and protein synthesis (Gomes et al. 2011) . Despite the therapeutic potential of these agents, obtaining them involves long and complex laboratory processes that have low yields. In addition, their study has not yet translated into tangible benefits because these active compounds are not in clinical use. However, people continue using the infusions of S. mexicanum to complement anticancer therapies, even though there is no scientific evidence to support the use of these infusions with a control of the composition and dosage or knowledge of their adverse effects.
Chemical compounds in the root bark of S. mexicanum ( Fig. 1) have been isolated and identified using different approaches. Reyes-Chilpa et al. (2003) reported the extraction of metabolites in the root bark of S. mexicanum in petroleum ether by maceration and obtained a yield of 0.73 wt.%. Chemical characterization of the extract indicated the presence of long-chain hydrocarbon compounds and four triterpenoids: b-sitosterol (I), pristimerin (II), canophyllol (III), and friedelin (IV). Other molecules identified include triterpenoids such as canophyllal (V) and canophyllic acid (VI), as well as the quinone methide triterpenes celastrol (VII), tingenone (VIII), and excelsin (IX) (Reyes-Chilpa et al. 2003) .
A Soxhlet extraction obtained in a mixture of hexane and diethylether (1:1) allowed for the isolation and identification of trans-polyisoprene (X), 21b-hydroxyolean-12-en-3-one (XI), dzununcanone (XII), 21a-hydroxy-3-oxofriedelane (XIII), and xuxarine Eb (XIV). 68.38 wt.% of the total extract corresponded to trans-1,4-polyisoprene (X), a white rubbery material that has been described as the largest component of the nonpolar (Mena-Rejón et al. 2007 ) and moderately polar (Reyes-Chilpa et al. 2003) extracts of S. mexicanum root bark.
The cytotoxic activity of S. mexicanum root bark was evaluated to determine if it has potential for application in the treatment of breast cancer. S. mexicanum root bark extracts were obtained by ultrasound-assisted extraction. This method significantly reduces the sample processing time and has not been used previously to obtain the active compounds of this plant species. Additionally, a method of fractionation by cryoprecipitation is presented, which makes it possible to obtain active fractions without the excessive use of organic solvents used in fractionation by column chromatography. Two fractions that are highly cytotoxic toward breast cancer cells were obtained, which demonstrates that S. mexicanum root bark has potential for the treatment of breast cancer and could be used for the development of anticancer drugs.
Materials and methods

Plant material
Semialarium mexicanum (Miers) Mennega root bark was purchased from the Santo Domingo Herbalist (Mexico City) and classified by the herbarium of the Universidad Autónoma de Chapingo, which retains a voucher specimen (number 33093). The plant material was sanitized, dried, and ground into particles with diameters less than 177 lm.
Obtainment of the extracts
The extraction was performed in an ultrasonic bath (Elma, Germany) at 30°C and 25 kHz for 30 min using solvents in a sequential order of polarity: petroleum ether, ethanol, and water. First, 75 g of powdered S. mexicanum root bark was mixed with 750 mL of solvent and extracted with three washes. The extracts were centrifuged at 5229g, decanted, filtered (Whatman No. 1), and dried (vacuum oven, Thelco, Precision Scientific, USA) at 40°C. All extracts were dissolved in dimethyl sulfoxide (DMSO, Sigma-Aldrich) Fig. 1 Chemical compounds present in non-polar extracts of S. mexicanum root bark. b-sitosterol (I), pristimerin (II), canophyllol (III), friedelin (IV), canophyllal (V), canophyllic acid (VI), celastrol (VII), tingenone (VIII), excelsin (IX), trans-1,4-polyisoprene (X), 21b-hydroxyolean-12-en-3-one (XI), dzununcanone (XII), 21a-hydroxy-3-oxofriedelane (XIII), and xuxarine Eb (XIV) (Reyes-Chilpa et al. 2003; Mena-Rejón et al. 2007) Physiol Mol Biol Plants (November-December 2018) 24(6): 1185-1201 1187 and stored at -20°C for preservation and sterilization (Cos et al. 2006) . Cells were seeded in 96-well plates at a confluence of 7000 cells per well for the MDA-MB-231 and MCF7 cell lines and 10,000 cells per well for the MCF 10A cells, with a total volume of 100 lL of the corresponding culture medium. Cultures were incubated at 37°C in a humidified atmosphere with 5% CO 2 for 24 h to allow the adhesion of the cells to the surface of the plate. The culture medium was then discarded, and 100 lL of medium containing the different treatments were added to each well.
First, the cytotoxicity of the petroleum ether, ethanol, and water extracts was tested on the MDA-MB-231 cells at concentrations of 15, 30, 45, and 60 lg/mL. Three controls were used: (a) a negative control of untreated cells; (b) a positive control of cells treated with paclitaxel 0.25 lg/ mL; and (c) a placebo control of cells treated with 0.2% v/v DMSO. The last control was used to evaluate the effect of the DMSO used to preserve and sterilize the extracts on the viability of the cells. In all cases, the DMSO added together with the extracts achieved a final concentration in the culture medium of less than 0.2% v/v. Once all the treatments were added, cells were incubated for 24 and 72 h at 37°C in a humidified atmosphere with 5% CO 2 . The cytotoxicity of the extracts was then determined by the MTT assay.
Only the extract obtained in petroleum ether was assayed for its cytotoxic activity on the MCF7 and MCF 10A cells due to its proven cytotoxicity. The protocol described for the MDA-MB-231 cells was used. The extract concentrations evaluated for these cell lines were 30, 45, 60, and 75 lg/mL in order to increase the cytotoxic effect and to determine the IC 50 values.
MTT assay
Once the treatments were completed, 0.1 mg of MTT reagent (Sigma-Aldrich) was added to each well, and the plates were incubated for 2 h at 37°C in humidified atmosphere with 5% CO 2 in darkness. After completing the incubation, the medium was removed, and 100 lL of DMSO were added. The absorbance of the samples was determined at 570 nm in an ELISA reader (Labsystem Multiskan MS, Thermo Scientific, USA). The different treatments were compared against the negative control, and the cell viability percentage was calculated.
PBMCs isolation and treatments
PBMCs were obtained from leukocyte packages of healthy donors (Blood Bank, Central Military Hospital, Mexico City) using the density gradient medium Lymphoprep (Axis-Shield) according to the manufacturer's instructions. The PBMCs were seeded in 96-well plates at a confluence of 50,000 cells per well in a volume of 50 lL of culture medium. The petroleum ether extract was tested for cytotoxicity on these cells by adding 50 lL of X-VIVO medium containing the different treatments to each well to obtain a final volume of 100 lL.
Petroleum ether extract was evaluated on the PBMCs at concentrations of 30, 45, 60, and 75 lg/mL. The positive, negative, and placebo controls were used as described for the cell lines. The cytotoxicity of the extract was determined by the WST-1 assay after 24 and 72 h of treatment.
WST-1 assay
After completing the treatments for the PBMCs, 10 lL of WST-1 reagent solution (Clontech) were added to each well. The cells were incubated for 90 min at 37°C in humidified atmosphere with 5% CO 2 . The plates were then shaken for 5 s, and the absorbance at 450 nm was determined using ELISA equipment. The different treatments were compared to the negative control, and the cell viability percentage was calculated.
Statistical analysis
All cytotoxicity assays were repeated at least 6 times. The results were analyzed through one-way ANOVA followed by Dunnett's multiple comparisons tests using GraphPad Prism version 7.00 for Windows (GraphPad Software, La Jolla California USA).
Analysis of apoptosis by flow cytometry
The induction of apoptosis by the petroleum ether extract was evaluated using the MDA-MB-231, MCF7, and MCF 10A cell lines by flow cytometry (Muse Cell Analyzer, Merck Millipore Corporation) with Annexin V for the detection of apoptotic cells and 7-amino-actinomycin D (7-AAD) to evaluate the loss of cell membrane integrity related to cell death (Schmid et al. 1992 ) (Muse Annexin V and Dead Cell Assay Kit, Merck Millipore Corporation). To achieve this, 260,000 cells per well were seeded in 6-well plates with 3 mL of the corresponding culture medium. The cells were incubated for 24 h at 37°C in 5% CO 2 to allow adhesion to the surface of the plate. The culture medium was then removed, and 3 mL of fresh medium was added with 60 lg/mL of the extract. Cells treated with 0.25 lg/mL of paclitaxel and untreated cells were used as controls. Treatments were maintained for 24 and 72 h at 37°C in 5% CO 2 . The culture medium and the trypsinized cells were then collected and centrifuged for 10 min at 1409g, and the cell pellet was resuspended in 200 lL of culture medium. Staining of the cells and flow cytometry assays were carried out according to the manufacturer's protocol.
Oxidative stress evaluation
Oxidative stress induction by the petroleum ether extract was evaluated using the MDA-MB-231, MCF7, and MCF 10A cell lines by flow cytometry (Muse Oxidative Stress kit, Merck Millipore Corporation). The production of intracellular superoxide radicals was determined, the results are expressed in terms of the ROS production, and the ROS(?) and ROS(-) cell percentages are indicated. For this evaluation, 260,000 cells per well were seeded in 6-well plates with 3 mL of the corresponding cell culture medium. Cells were incubated for 24 h at 37°C in 5% CO 2 to allow adhesion to the surface of the plate. The culture medium was then removed, and 3 mL of fresh medium containing 60 lg/mL of the petroleum ether extract were added. Cells treated with paclitaxel 0.25 lg/mL and untreated cells were used as controls. Treatments were maintained for 24 and 72 h. The culture medium and the trypsinized cells were then collected and centrifuged for 10 min at 1409g, and the cell pellet was resuspended in 40 lL of culture medium. The staining of the cells and the flow cytometry assays were done according to the manufacturer's protocol.
Fractionation by cryoprecipitation
The petroleum ether root bark extract was fractionated by cryoprecipitation (precipitation at low temperature). After ultrasound-assisted extraction, the petroleum ether extract containing all the metabolites was stored at -20°C for 48 h to allow the precipitation of the gum present in it. The extract was then filtered and dried in a vacuum oven. The dried material was resuspended in 40 mL of petroleum ether and centrifuged at 5229g for 15 min. The supernatant was stored at -20°C for 48 h and centrifuged again. A final precipitation process was applied to the supernatant at -20°C for 24 h. The samples were centrifuged to obtain two fractions: the sediment (a pale yellow powder) and the supernatant. The supernatant was concentrated in a vacuum oven, which produced an oily fraction with an intense red color.
Cytotoxicity assays of the fractions
Both the oil (supernatant) and powder (sediment) fractions were tested for cytotoxicity using the protocol described above using concentrations of 2.5, 5, 10, 15, 20, and 25 lg/ mL.
Selectivity index determination
To determine whether the S. mexicanum root bark petroleum ether extract and its fractions are selective for the breast cancer cells, the selectivity index (SI) was calculated using IC 50 of the evaluated treatment in normal cells, which was divided by IC 50 of the evaluated treatment in cancerous cells to obtain SI. IC 50 is the concentration of the extract or fraction needed to reduce the cell viability to 50% with respect to untreated cells (Badisa et al. 2009 ).
Chemical characterization of the cryoprecipitated gum by FT-IR spectroscopy
The gum removed from the petroleum ether extract was characterized by FT-IR spectroscopy (Agilent Cary 630 FT-IR Spectrometer) in the range of 650-4000 cm -1 . The spectrum was analyzed using Essential FT-IR spectroscopy software (Operant LLC, USA).
HPLC analysis
The oily and the powdered fractions were evaluated by UV-Vis spectroscopy to identify the absorbance signals to be used in the chromatographic studies. The samples were then prepared for HPLC analysis as follows. First, 50 mg of the oily fraction was diluted in 1 mL of a mixture of MeOH:H 2 O (95:5 v/v) and sonicated (45 kHz) for 10 min. The sample was then centrifuged at 84529g for 15 min at room temperature. The supernatant was diluted in 1.5 mL of a solution of MeOH/(H 2 O:H 3 PO 4 (0.5%)) (70:30 v/v). Furthermore, 2.5 mg of the powdered fraction was dissolved in 1 mL of a solution of MeOH/(H 2 O:H 3 PO 4 (0.5%)) (80:20 v/v). Both fractions were filtered through a 0.45-lm PVDF membrane before chromatographic analyses.
Chemical fingerprint of the fractions, identification and quantification of pristimerin (HPLC-DAD)
HPLC analyses were carried out using an Agilent 1200 series HPLC-DAD (Agilent Technologies, Waldbronn, Germany) equipped with a Zorbax Eclipse Plus C18 column (Agilent Technologies, Waldbronn, Germany) (4.6 9 100 mm, 3.5 lm). The mobile phase consisted of a mixture of H 2 O:H 3 PO 4 (99.5:0.5) as eluent A and MeOH as eluent B. The system was run with a gradient program according to the method proposed by Araujo Leon et al. (2015) with minor modifications: 55-70% B, 0-10 min; 70-85% B, 10-15 min; 85-90% B, 15-23 min and 90-100% B, 23-33 min, followed by isocratic elution with 100% B for 3 min. The column temperature was set at 30°C, the flow rate was set at 0.7 mL/min, and the injection volume was 5 lL. Chromatograms were acquired at 290 and 420 nm. Pristimerin was identified at 420 nm using a commercial standard (530070, Merck Millipore). A standard calibration curve (0.05-1.0 mg/mL) was prepared and used for quantitative analysis.
Results and discussion
Petroleum ether extract of S. mexicanum root bark is cytotoxic for MDA-MB-231, MCF7, and MCF 10A cells
In the MDA-MB-231 cells (Fig. 2a) , the S. mexicanum root bark petroleum ether extract induced cell proliferation after 24 h of treatment with 15 and 30 lg/mL. Statistically insignificant changes were observed for 45 lg/mL with respect to the control of untreated cells, while increasing of the extract concentration to 60 lg/mL significantly reduced the cell viability to 63%. For 72 h of treatment, the proliferative effect of low concentrations (15 and 30 lg/mL) observed at 24 h decreased, while the cytotoxic activity of higher concentrations was increased, achieving 26% cell viability at 60 lg/mL.
All the evaluated concentrations of the ethanolic extract showed time-and concentration-dependent proliferative effects for both 24 and 72 h of treatment. The water extract did not induce statistically significant changes in cell viability at 24 h for all the evaluated concentrations. At 72 h, values greater than or equal to 30 lg/mL induced higher viability values with respect to the control of untreated cells, but the viability was similar to those obtained for the control with 0.2% DMSO, suggesting that this effect could be exerted by DMSO (Wen et al. 2015; Singh et al. 2017 ). Paclitaxel at 0.25 lg/ml reduced the cell viability to 82% at 24 h of exposure and 34% at 72 h.
The traditional use of S. mexicanum suggests drinking an aqueous infusion of the root bark to obtain therapeutic effects (Reyes-Chilpa et al. 2003) . However, in our research, only the petroleum ether extract induced cytotoxicity, whereas the aqueous extract was not cytotoxic for the MDA-MB-231 cells. This observation agrees with the report by Popoca et al. (1998) , in which the petroleum ether extract of the whole root of S. mexicanum showed greater cytotoxic activity toward cancerous cells compared to the extracts obtained in solvents with greater polarity (Popoca et al. 1998) .
Because only the petroleum ether extract showed cytotoxicity toward MDA-MB-231 cells, the studies of the other cell types were done using this extract. Concentrations of 30, 45, 60, and 75 lg/mL were evaluated to calculate the IC 50 values. In the MCF7 cells (Fig. 2b) , a proliferative effect was observed at 24 h for the lowest concentration, whereas for 45 and 60 lg/mL, no statistically significant changes were observed with respect to untreated cells. At 75 lg/mL, the cell viability decreased to 87%. After 72 h of treatment, the proliferative effect observed for 30 lg/mL at 24 h was enhanced, reaching a viability of 150%. A concentration-dependent cytotoxic effect was observed for higher values, with a viability of 60% observed for 75 lg/mL. Cells treated with DMSO showed no statistically significant changes in cell viability for the two evaluated times, while paclitaxel reduced cell viability to 78% at 24 h and 49% after 72 h.
Subsequently, the extract was evaluated with MCF 10A, a non-tumorigenic cell line derived from mammary tissue (Fig. 2c) . A cytotoxic effect was not observed in this cell line after 24 h of treatment with the concentrations evaluated, but after 72 h of exposure, a concentration-dependent cytotoxic effect was induced with 45, 60, and 75 lg/ mL. The controls did not show statistically significant changes at 24 h, while at 72 h, a decrease in cell viability was observed for both DMSO (81%) and paclitaxel (75%).
In summary, the petroleum ether extract of S. mexicanum root bark induced a proliferative effect for both breast cancer-derived cell lines in concentrations less than or equal to 30 lg/mL, showing no statistically significant changes in the non-tumorigenic cell line (MCF 10A). Higher concentrations induced cytotoxicity for all three cell lines. This behavior could suggest that the extract contains components that promote the proliferation of the tumor cells and a cytotoxic effect. In that case, it would be desirable to remove the components that exert the proliferative effect to promote the cytotoxicity. IC 50 values for the three cell lines after 24 h of treatment were higher than the evaluated concentrations used, whereas IC 50 values of 55.5 (MDA-MB-231), 66.8 (MCF 10A), and 75.8 (MCF7) lg/mL were obtained after 72 h of treatment Finally, the extract was evaluated using PBMCs (Fig. 2d) to explore its toxicity on the immune system. No statistically significant changes were observed after 24 or 72 h of treatment with 30, 45, and 60 lg/mL. Viabilities of 86% at 24 h and 79% at 72 h were obtained for the assays with 75 lg/mL. Interestingly, the extract did not induce a proliferative effect on non-tumorigenic cells (MCF 10A and PBMCs), and it exerted a much lower cytotoxic effect on PBMCs when compared to the evaluated cell lines. The viability observed for PBMCs treated with 60 lg/mL of the extract after 72 h was 91%, a much higher value than those obtained for the two breast cancer-derived cell lines (26% for MDA-MB-231 and 68% for MCF7).
A proliferative effect was observed for DMSO on the PBMCs at 24 and 72 h of treatment. However, paclitaxel did not show statistically significant changes at 24 h, whereas it exerted a proliferative effect after 72 h. Other studies have reported that the proliferative effect of paclitaxel on PBMCs corresponds to an immunomodulatory effect (Kaneno et al. 2011 ). This phenomenon gives advantages to paclitaxel over other antineoplastic agents by promoting the activity of the immune system on tumor cells. However, this effect has also been associated with hypersensitivity reactions experienced by patients treated with this drug (Fitzpatrick and Wheeler 2003) .
Petroleum ether extract of S. mexicanum root bark induces cell death via apoptosis
Flow cytometry assays were performed to evaluate the induction of apoptosis by the petroleum ether extract (60 lg/mL) in MDA-MB-231, MCF7, and MCF 10A cells. The following were used as controls: untreated cells (negative control) and cells treated with 0.25 lg/mL of paclitaxel (positive control) (Wang et al. 2000) . For the interpretation of the apoptosis results, four cell populations were generated as a function of the signal obtained with Annexin V and 7-AAD: (1) live cells (Annexin V-/7-AAD-); (2) cells in early apoptosis (Annexin V?/7-AAD-); (3) cells in late apoptosis/dead (Annexin V?/7-AAD?); and (4) dead cells (Annexin V-/7-AAD?).
After 24 h of incubation, all three cell lines without treatment (negative control, see Fig. 3a, d, and g ) showed values of live cells higher than 90% of the population. Minor changes were observed at 72 h of incubation (Fig. 4a, d, and g ). Paclitaxel induced cell death by apoptosis in the breast cancer-derived cells after 24 h of treatment (Fig. 3b, e) , reducing the percentage of live cells to 72.73 and 50.52% for MDA-MB-231 and MCF7, respectively. MCF 10A cells showed no major changes (Fig. 3h) when compared with the negative control, indicating a minor induction of cell death in this cell line.
After 72 h of treatment, paclitaxel significantly reduced the percentage of live cells in all three cell lines (Fig. 4b , e, and h) when compared to the negative control in the same period of incubation (Fig. 4a, d, and g ). Paclitaxel induced significant increases in the percentages of cells in early and late apoptosis for all the experiments. The MDA-MB-231 and MCF7 cell lines (Fig. 4b, e) showed mostly events of late apoptosis or dead (41.04 and 35.39%, respectively), while the MCF 10A cells (Fig. 4h) presented a higher number of events in early apoptosis (53.52%). (Fig. 3c, f) compared to the negative control (Fig. 3a, d) . These values are lower than those obtained with the positive control (Fig. 3b, e) . However, MCF 10A cells treated with the extract (Fig. 3i) showed no significant changes in comparison to the negative control for the same incubation time.
After 72 h of treatment, the extract induced an accumulation of cells in early apoptosis (34.45%) for MDA-MB-231 cells (Fig. 4c) , decreasing the percentage of live cells to 50.18%. In MCF7 cells (Fig. 4f) , the extract increased the population of cells in early apoptosis (31.90%) with a percentage of 60.25% for live cells. Finally, for the MCF 10A cells, the treatment with the extract (Fig. 4i) resulted in 73.03% live cells, 23.76% of cells in early apoptosis and 3.09% in late apoptosis/dead. Cancer cells were more sensitive to the induction of apoptosis by the petroleum ether extract. The results suggest that this pathway is the main mechanism of cell death induced by the extract because the percentage of nonapoptotic cell death (Annexin V-/7-AAD?) was negligible for all the experiments. Petroleum ether extract of S. mexicanum root bark induces oxidative stress
The cell death induced by the petroleum ether extract may be associated with the production of ROS if it contains pristimerin (Bashir et al. 2017) . For that reason, the induction of oxidative stress was evaluated in the three cell lines (MDA-MB-231, MCF7, and MCF 10A) after 24 and 72 h of incubation. The results are shown in Fig. 5 and 6 , where M1 represents the population of ROS(-) cells, and M2 represents the ROS(?) cells. The basal ROS production for the three cell lines (negative controls) evaluated after 24 h of incubation is shown in Fig. 5a, d , and g. More than 86% of the cells were negative for ROS in these controls. The use of paclitaxel induced a significant increase in the percentage of ROS(?) cells for MDA-MB-231 (21.08%) and MCF 10A (31.92%) cells (Fig. 5b, h ), while MCF7 cells (Fig. 5e) showed no major changes compared to the negative control. ROS generation has been previously described as an important factor in the induction of cell death by paclitaxel (Alexandre et al. 2007; Varbiro et al. 2001) . The treatment with the petroleum ether extract induced an increase in the population of ROS(?) cells for the three cell lines (Fig. 5c , f, and i) when compared to the negative controls, with values of 18.33, 26.78, and 22.87% ROS(?) cells for MDA-MB-231, MCF7, and MCF 10A, respectively.
The basal ROS production for the three cell lines (negative controls) evaluated after 72 h of incubation is shown in Fig. 6a, d , and g, where more than 80% of the cells were ROS(-) for the three cell lines. After 72 h of treatment, paclitaxel showed a significant induction of ROS production in the MCF7 and MCF 10A cell lines (Fig. 6e,  h ) with 48.66 and 44.42% of ROS(?) cells, respectively. The MDA-MB-231 cells (Fig. 6b) showed a lower induction of ROS. The petroleum ether extract increased ROS (Fig. 6c, f, and i) .
It has been proven that a wide range of anticancer agents are active because of their ability to induce the generation of ROS in malignant cells (Yadav et al. 2015) . This occurs because the damage produced by oxidative stress leads to the activation of stress-responsive transcription factors that induce apoptosis. This ROS production also affects the mitochondrial activity, inducing a depletion of ATP (Ozben 2007) . The petroleum ether extract of S. mexicanum root bark may induce a significant decrease in the mitochondrial function in the three cell lines evaluated. This is evidenced by the results of the MTT assays, as well as an increased generation of ROS, leading to cell death via apoptosis. All these results suggest that the root bark of S. mexicanum may have applications in the treatment of breast cancer. Thus, this extract is a candidate for further investigations for the possible development of anticancer drugs.
Fractionation of the petroleum ether extract of S. mexicanum root bark
Fractionation was performed by cryoprecipitation to remove the gum and partially purify the active compounds contained in the petroleum ether extract to improve its cytotoxic activity. This gum was identified by FT-IR spectroscopy as trans-1,4-polyisoprene (structure X in Fig. 1 ), which has previously been identified in S. mexicanum (Mena-Rejón et al. 2007 ). The spectrum and the assignment of the signals are shown in Fig. 7 .
After removing the gum, two fractions were obtained. The first fraction was obtained as a pale yellow powder, whereas the second fraction showed an intense red color and oily aspect. The method used to obtain these fractions is shown in Fig. 8 , including the yields of each step. 
M1 represents the population of ROS(-) cells and M2 represents the population of ROS(?) cells
Fractions of the S. mexicanum root bark petroleum ether extract are highly cytotoxic for breast cancer cells Both fractions were evaluated for cytotoxicity in the MDA-MB-231 cell line (Fig. 9a) at 2.5, 5, 10, 15, 20, and 25 lg/ mL for 24 and 72 h. The fractionation process markedly increased the cytotoxic effect of fractions when compared to the complete extract, with a decrease in cell viability observed from 2.5 lg/mL. IC 50 values of 6.83 and 4.80 lg/ mL were obtained for the oily fraction at 24 and 72 h, respectively. The powdered fraction showed a better cytotoxic effect with IC 50 values of 5.98 and 3.35 lg/mL at 24 and 72 h, respectively. In both cases, the effect was dependent on the concentration and time.
A concentration-and time-dependent cytotoxic effect was also observed for the MCF7 cell line with the oily fraction (Fig. 9b) . At the highest concentration, a viability of 46% was obtained at 24 h of exposure, while 7% was obtained at 72 h. The IC 50 values were 23.82 and 8.06 lg/ mL, respectively. For the powder, the cytotoxic effect was even greater, with a viability of 10% at 24 h for the highest concentration and 0% for treatments C 20 lg/mL after 72 h. The IC 50 values were 9.94 and 4.15 lg/mL, respectively. Fig. 8 Flowchart of the extractive procedures and the fractions generated. The S. mexicanum root bark was extracted by ultrasoundassisted extraction using petroleum ether, ethanol, and water. The petroleum ether extract was fractionated by cryoprecipitation, trans-1,4-polyisoprene was removed from the extract, and two fractions (powder and oily) containing pristimerin were obtained
The non-tumorigenic cells derived from mammary tissue MCF 10A (Fig. 9c) showed a lower sensitivity to the fractions when compared to the tumor cells. At 24 h, the oily fraction induced an effect on cell viability for treatments C 20 lg/mL only, decreasing the viability to 67.5% for the highest concentration with an estimated IC 50 value of 34.6 lg/mL. The increase in the treatment time (72 h) induced a greater cytotoxic effect, and the cell viability decreased for concentrations C 10 lg/mL with an IC 50 value of 15.55 lg/mL. The powder showed a greater cytotoxic effect, decreasing cell viability with concentrations C 10 lg/mL at 24 h with an IC 50 value of 21.45 lg/ mL. At 72 h, the cell viability decreased from 5 lg/mL with an IC 50 of 8.97 lg/mL.
Finally, both fractions were evaluated with PBMCs (Fig. 9d) . For the oily fraction, there were no statistically significant changes for the concentrations of 2.5-15 lg/mL at 24 h of treatment, but greater values induced a concentration-dependent cytotoxic effect, with IC 50-= 24.89 lg/mL. After 72 h of treatment, a recovery in the cell viability was observed, and none of the evaluated concentrations exerted cytotoxicity for this incubation time. A similar case was observed for the powdered fraction. This fraction showed a greater cytotoxic effect than the oily fraction on PBMCs at 24 h, reaching an IC 50 of 10.21 lg/mL. However, at 72 h, the cells recovered their viability, with no cytotoxicity occurring for the evaluated concentrations.
The IC 50 values obtained for both fractions with cancerderived cells are important results when taking the recommendations of the US National Cancer Institute (USA NCI) into account. The recommendations suggest that pure compounds with cytotoxic IC 50 values B 4 lg/ml are considered active (Alonso-Castro et al. 2011 ) and promising for the development of anticancer drugs. This is even more important when considering that the fractions are not pure substances but mixtures of compounds. The increase of cytotoxicity when the gum was removed from the extract may have a relationship with previous reports of trans-1,4-polyisoprene (the main component of the gutta-percha) as an inductor of cell growth and differentiation (Zhang et al. 2016) . Polyisoprenes can participate as initial substrates of the mevalonate pathway and promote cell proliferation, particularly in tumor cells (Mullen et al. 2016 ).
Fractionations of S. mexicanum root bark petroleum ether extract are selective for breast cancer cells Selectivity indexes were calculated for the whole petroleum ether extract of S. mexicanum root bark as well as the powder and oil fractions (Table 1 ) after 72 h of treatment. IC 50 values obtained for the two breast cancer cell lines (MDA-MB-231 and MCF7) were compared to those obtained for two non-tumorigenic cell types (MCF 10A derived from human breast tissue and PBMCs immunological cells). The SI calculation allows for the evaluation of the differential activity of the compounds on tumor cells and normal cells. The greater the SI value is, the more selective the compound is. An SI value less than 2 indicates general toxicity of the analyzed compound (Badisa et al. 2009 ).
The whole petroleum ether extract of the S. mexicanum root bark was not selective for breast cancer cells when compared to normal breast-derived cells (MCF 10A). The selectivity of this extract when breast cancer cells were compared to the PBMCs was not determined because the IC 50 value for the PBCMs was higher than the concentrations evaluated. However, the results show that the cytotoxicity of the whole petroleum ether extract of the S. mexicanum root bark on the breast cancer cells is equal to or greater than that exerted on the PBMCs.
Fractionation of the extract markedly increased the selectivity. Both the powder and oil fractions were highly selective for MDA-MB-231 cells when compared to MCF 10A and PBMCs. The powder fraction was selective for MCF7 cells when compared to MCF 10A cells, but the oily fraction was not selective. However, there is a high selectivity of both fractions between MCF7 and PBMCs. These results suggest that the obtained fractions are potential candidates for the development of drugs to treat breast cancer.
Pristimerin is present in the fractions of the S. mexicanum root bark petroleum ether extract Both fractions were evaluated by HPLC at 290 and 420 nm. The chromatograms are presented in Fig. 10 . Pristimerin was identified at 420 nm with a retention time of 24.435 min by comparison to the retention time and maximum UV absorption (420 nm) with a commercial standard. An internal standard was used to corroborate the pristimerin identity. A standard calibration curve with a linearity range of 0.05-1.00 mg/mL (R 2 = 0.9936) was prepared and used for quantitative analysis.
Pristimerin was a predominant compound with the highest percentage of peak area in both fractions at 420 nm: 38.36% for the powdered fraction and 63.73% for the oily fraction. For the oily fraction, a yield of 8.90 ± 1.02 mg of pristimerin/kg of dry vegetal material was obtained. For the powdered fraction, a yield of 9.68 ± 1.31 mg of pristimerin/kg of dry vegetal material was determined. The differences in yields between fractions were not significant. The cytotoxic effect of the petroleum ether extract may be explained by its content of pristimerin, which induces both the apoptosis and oxidative stress phenomena observed for the extract (Bashir et al. 2017) . However, tingenone as well as other compounds with cytotoxic activity could be present in the extract and produce a synergistic cytotoxic effect. The fractionation of the extract by cryoprecipitation allowed for the elimination of trans-1,4-polyisoprene and the generation of two fractions that are highly cytotoxic and specific for breast cancer cells. The cytotoxic effect of these two fractions could be exerted by pristimerin as well as other components present in the fractions. Future investigations should be developed to identify the other components. This research supports the potential use of S. mexicanum root bark for the development of drugs to treat breast cancer. 
Conclusions
The petroleum ether extract of S. mexicanum root bark induced cell death by apoptosis in MDA-MB-231, MCF7, and MCF 10A cells. This cell death was associated with decreased metabolic activity and the generation of ROS. The extract was fractionated by cryoprecipitation, and two fractions that are highly cytotoxic and specific for breast cancer cells were obtained. Both fractions showed IC 50 values that are low enough for them to be considered as potential candidates for the treatment of cancer according to the recommendations of the US NCI. Pristimerin is present in both fractions and may be partially responsible for the cytotoxicity induced by the extract and its fractions. The obtained fractions are promising for the development of anticancer drugs, not only because of the low IC 50 values, but also because their obtainment is simple and does not require chromatographic techniques or the use of large quantities of solvents.
